With this, it is highly probable that in non-tumor cells, STING pathway activation would induce IFNs more intensely than BxPC-3 cells and would be far more responsive than Capan-2 cells, sufficient to suppress C-REV replication. The gene discussed is STING1; the disease is neoplasm.